These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1209 related items for PubMed ID: 32200293

  • 1. Arecoline suppresses RANKL-induced osteoclast differentiation in vitro and attenuates LPS-induced bone loss in vivo.
    Liu FL, Chen CL, Lai CC, Lee CC, Chang DM.
    Phytomedicine; 2020 Apr; 69():153195. PubMed ID: 32200293
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Poligoni Multiflori Radix enhances osteoblast formation and reduces osteoclast differentiation.
    Han SY, Lee KH, Kim YK.
    Int J Mol Med; 2018 Jul; 42(1):331-345. PubMed ID: 29620250
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Ganomycin I from Ganoderma lucidum attenuates RANKL-mediated osteoclastogenesis by inhibiting MAPKs and NFATc1.
    Tran PT, Dat NT, Dang NH, Van Cuong P, Lee S, Hwangbo C, Van Minh C, Lee JH.
    Phytomedicine; 2019 Mar 01; 55():1-8. PubMed ID: 30668419
    [Abstract] [Full Text] [Related]

  • 7. Streptococcus gordonii induces bone resorption by increasing osteoclast differentiation and reducing osteoblast differentiation.
    Park OJ, Kim J, Kim HY, Kwon Y, Yun CH, Han SH.
    Microb Pathog; 2019 Jan 01; 126():218-223. PubMed ID: 30414445
    [Abstract] [Full Text] [Related]

  • 8. Sappanone A inhibits RANKL-induced osteoclastogenesis in BMMs and prevents inflammation-mediated bone loss.
    Choo YY, Tran PT, Min BS, Kim O, Nguyen HD, Kwon SH, Lee JH.
    Int Immunopharmacol; 2017 Nov 01; 52():230-237. PubMed ID: 28946117
    [Abstract] [Full Text] [Related]

  • 9. Emodin regulates bone remodeling by inhibiting osteoclastogenesis and stimulating osteoblast formation.
    Kim JY, Cheon YH, Kwak SC, Baek JM, Yoon KH, Lee MS, Oh J.
    J Bone Miner Res; 2014 Jul 01; 29(7):1541-53. PubMed ID: 25832436
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Water extract of Rumex crispus prevents bone loss by inhibiting osteoclastogenesis and inducing osteoblast mineralization.
    Shim KS, Lee B, Ma JY.
    BMC Complement Altern Med; 2017 Oct 26; 17(1):483. PubMed ID: 29070038
    [Abstract] [Full Text] [Related]

  • 12. Substance P stimulates bone marrow stromal cell osteogenic activity, osteoclast differentiation, and resorption activity in vitro.
    Wang L, Zhao R, Shi X, Wei T, Halloran BP, Clark DJ, Jacobs CR, Kingery WS.
    Bone; 2009 Aug 26; 45(2):309-20. PubMed ID: 19379851
    [Abstract] [Full Text] [Related]

  • 13. Agrimophol suppresses RANKL-mediated osteoclastogenesis through Blimp1-Bcl6 axis and prevents inflammatory bone loss in mice.
    Cao J, Wang S, Wei C, Lin H, Zhang C, Gao Y, Xu Z, Cheng Z, Sun WC, Wang HB.
    Int Immunopharmacol; 2021 Jan 26; 90():107137. PubMed ID: 33199235
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Ethanol extract of Polyscias fruticosa leaves suppresses RANKL-mediated osteoclastogenesis in vitro and LPS-induced bone loss in vivo.
    Tran PT, Dang NH, Kim O, Van Cuong P, Dat NT, Hwangbo C, Van Minh C, Lee JH.
    Phytomedicine; 2019 Jun 26; 59():152908. PubMed ID: 30981187
    [Abstract] [Full Text] [Related]

  • 16. Chlorogenic acid inhibits osteoclast differentiation and bone resorption by down-regulation of receptor activator of nuclear factor kappa-B ligand-induced nuclear factor of activated T cells c1 expression.
    Kwak SC, Lee C, Kim JY, Oh HM, So HS, Lee MS, Rho MC, Oh J.
    Biol Pharm Bull; 2013 Jun 26; 36(11):1779-86. PubMed ID: 23985829
    [Abstract] [Full Text] [Related]

  • 17. Desoxyrhapontigenin inhibits RANKL‑induced osteoclast formation and prevents inflammation‑mediated bone loss.
    Tran PT, Park DH, Kim O, Kwon SH, Min BS, Lee JH.
    Int J Mol Med; 2018 Jul 26; 42(1):569-578. PubMed ID: 29693149
    [Abstract] [Full Text] [Related]

  • 18. Chalcone T4 Inhibits RANKL-Induced Osteoclastogenesis and Stimulates Osteogenesis In Vitro.
    de Matos IAF, Fernandes NAR, Cirelli G, de Godoi MA, de Assis LR, Regasini LO, Rossa Junior C, Guimarães-Stabili MR.
    Int J Mol Sci; 2023 Apr 21; 24(8):. PubMed ID: 37108787
    [Abstract] [Full Text] [Related]

  • 19. Protocatechuic Acid Attenuates Osteoclastogenesis by Downregulating JNK/c-Fos/NFATc1 Signaling and Prevents Inflammatory Bone Loss in Mice.
    Park SH, Kim JY, Cheon YH, Baek JM, Ahn SJ, Yoon KH, Lee MS, Oh J.
    Phytother Res; 2016 Apr 21; 30(4):604-12. PubMed ID: 26792397
    [Abstract] [Full Text] [Related]

  • 20. 2E-Decene-4,6-diyn-1-ol-acetate inhibits osteoclastogenesis through mitogen-activated protein kinase-c-Fos-NFATc1 signalling pathways.
    Park YR, Su XD, Shrestha SK, Yang SY, Soh Y.
    Clin Exp Pharmacol Physiol; 2022 Mar 21; 49(3):341-349. PubMed ID: 34729812
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 61.